Trích dẫn APA

Sanford, D., Wierda, W. G., Burger, J. A., Keating, M. J., & O’Brien, S. M. (2015). Three newly approved drugs for chronic lymphocytic leukemia (CLL): Incorporating ibrutinib, idelalisib and obinutuzumab into clinical practice. Clin Lymphoma Myeloma Leuk.

Trích dẫn kiểu Chicago

Sanford, David, William G. Wierda, Jan A. Burger, Michael J. Keating, và Susan M. O’Brien. "Three Newly Approved Drugs for Chronic Lymphocytic Leukemia (CLL): Incorporating Ibrutinib, Idelalisib and Obinutuzumab Into Clinical Practice." Clin Lymphoma Myeloma Leuk 2015.

Trích dẫn MLA

Sanford, David, et al. "Three Newly Approved Drugs for Chronic Lymphocytic Leukemia (CLL): Incorporating Ibrutinib, Idelalisib and Obinutuzumab Into Clinical Practice." Clin Lymphoma Myeloma Leuk 2015.

Cảnh báo: Các trích dẫn này có thể không phải lúc nào cũng chính xác 100%.